PATENT CLAIM ANALYSIS

Application Number: 15934790
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-09
Patent Classification: ["424", "457000"]

Abstract:
Methods of administering methyldopa to a subject in a fasting state to increase bioavailability of the methyldopa.

Claim (Index 5):
The method of  claim 1 , wherein the oral D-\u03b1-methyldopa dosage formulation is administered with at least 200 ml of water.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 90.0
- Lexical Diversity: 1.28571
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['10800990', '15466026', '10480293', '12128225', '12327477']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7360151930070796
- 35 USC 102 Novelty (BERT): 0.4931348862479452
- Combined Prediction Score: 0.7117271623311663
- Mean Citation Score: 205.417724
- Max Citation Score: 219.83327000000003
- Similarity Product: 158.08116069951538

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test